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Abstract
Background: Disordered eating behavior and body dissatisfaction affect a large proportion of the Dutch
population and account for severe psychological, physical and social morbidity. Yet, the threshold for seeking
professional care is still high. In the Netherlands, only 7.5% of patients with bulimia nervosa and 33% of patients
with anorexia nervosa are treated within the mental health care system. Easily accessible and low-threshold
interventions, therefore, are needed urgently. The internet has great potential to offer such interventions. The
aim of this study is to determine whether a web-based treatment program for patients with eating disorders can
improve eating disorder psychopathology among female patients with bulimia nervosa, binge eating disorder
and eating disorders not otherwise specified.
Methods/design: This randomized controlled trial will compare the outcomes of an experimental treatment
group to a waiting list control group. In the web-based treatment program, participants will communicate personally
and asynchronously with their therapists exclusively via the internet. The first part of the program will focus on
analyzing eating attitudes and behaviors. In the second part of the program participants will learn how to change
their attitudes and behaviors. Participants assigned to the waiting list control group will receive no-reply email
messages once every two weeks during the waiting period of 15 weeks, after which they can start the program.
The primary outcome measure is an improvement in eating disorder psychopathology as determined by the Eating
Disorder Examination Questionnaire. Secondary outcomes include improvements in body image, physical and mental
health, body weight, self-esteem, quality of life, and social contacts. In addition, the participants’ motivation for
treatment and their acceptability of the program and the therapeutic alliance will be measured. The study will
follow the recommendations in the CONSORT statement relating to designing and reporting on RCTs.
(Continued on next page)
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Discussion: This study protocol presents the design of a RCT for evaluating the effectiveness of a web-based
treatment program using intensive therapeutic support for female patients with bulimia nervosa, binge eating
disorder and eating disorders not otherwise specified.
Trial registration: The protocol for this study is registered with the Netherlands Trial Registry NTR2415.
Keywords: Eating disorders, Bulimia nervosa, Binge eating disorder, Eating disorders not otherwise specified,
Randomized controlled trial, Web-based treatment program, e-health, Intensive therapeutic support,
Asynchronous support
Background
A significant part of the Dutch population suffers from
disordered eating behavior and body dissatisfaction.
According to a recent review on the epidemiology of
eating disorders, the incidence of anorexia nervosa
(AN) in the Netherlands over the past decade has
remained stable at around 7 per 100,000 persons per
year [1]. For bulimia nervosa (BN) the incidence rate
has been estimated at 6.1 per 100,000 persons per year
[1]. The latest incidence numbers of AN and BN in the
Netherlands are, however, from a national primary care
study dated 1995–1999 [1]. In a population-based study
in six European countries, including the Netherlands,
the lifetime prevalence of AN and BN was estimated to
be 0.48% and 0.51%, respectively [2]. For the Netherlands,
the lifetime prevalence estimates were somewhat lower
compared to the other countries (except for Germany) [2].
In addition to AN and BN, the most common eating
disorder diagnosis is the category ‘eating disorders not
otherwise specified’ (EDNOS), including binge eating
disorder (BED) [3,4]. In the six European countries
studied, the lifetime prevalence of BED was 1.12% [2].
Eating disorders can have severe psychological, physical
and social consequences, and clearly affect the quality
of life of the patient [5-7]. Despite all the negative con-
sequences, many patients do not seek or receive mental
health care [8-10]. Barriers that prevent patients from
seeking help include feelings of shame, fear of stigma, a
lack of awareness, denial of the disorder, low motivation
for treatment, availability of health services, mistrust in
the system, and the high cost [11-15]. According to a
review by Smink, van Hoeken & Hoek, only 7.5% of all
patients with BN and 33% of all patients with AN are
treated within the mental health care system [1]. The
threshold for seeking professional care is high. Conse-
quently, there is an urgent need for easily accessible
and low-threshold interventions.
The internet with its widespread access and increasing
usage, offers a great opportunity to administer appealing
and accessible interventions for patients with eating
disorders. Internet interventions can offer a high degree
of anonymity that may encourage patients who are
ashamed of their eating problems to seek help. They
can also offer instant and easy access to treatment for
patients living in rural and remote locations [16-19].
Newly developed internet interventions have already been
applied successfully for various mental health illnesses,
including alcohol abuse [20-22], depression [23-25] and
anxiety disorders [24,26-28].
Several studies have been conducted into web-based
interventions designed to prevent eating disorders [29,30].
However, the number of studies that focus on the treat-
ment of eating disorders through web-based interventions
is rather limited. A recently conducted systematic review
on internet-based treatment of eating disorders [31] found
that such treatments were more effective than waiting
lists in reducing eating disorder psychopathology, frequency
of binge eating and purging, and in improving quality of
life. However, according to the authors, the methodological
quality of the studies varied. The internet-based treatments
the review investigated differed considerably in the intensity
of therapeutic support [31]. Some studies involved self-help
or minimal contact interventions, whereas others included
weekly contact between participants and their coaches
or licensed therapists. Research in the field of depression
and anxiety has shown that interventions using (intensive)
therapeutic support are more effective than self-help or
minimal contact interventions [24,32-34]. For web-based
treatments on eating disorders, however, similar research
is scarce. According to Aardoom and colleagues, face-to-
face contacts and therapeutic support seem to increase
study compliance and possibly also treatment compliance,
as therapist support appears to play an important role in
enhancing participants’ motivation [31]. However, more
research is needed on the role of therapeutic support in
web-based treatments on eating disorders, with regard to the
optimal frequency, amount, type and provider of support.
In the Netherlands, several mental health care institu-
tions provide web-based treatments for patients with
eating disorders. As far as we know, only two of these
interventions have been studied to date [35-37], and just
one of them was conducted among the Dutch population
of patients with eating disorders (specifically BN) [37].
This study included a randomized controlled trial (RCT)
on an asynchronous web-based treatment program
with intensive therapeutic support (25 scheduled clinician
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feedback moments) among Dutch patients with BN.
The RCT showed that the intervention was effective in
decreasing disordered eating behavior (measured with
the EDE-Q; d = 1.5, p <0.001) and body dissatisfaction
(measured with the BAT; d = 0.7, p <0.001) [37]. Also, the
frequency of binge eating and purging reduced from 15
and 14, respectively, at pre-test, to 2 and 0, respectively,
at post-test (both p <0.001).
So far, the effects of web-based treatments have not
been analyzed for patients with BED and EDNOS in
the Netherlands. Given the high prevalence of these
eating disorders, it would be interesting to investigate
whether a web-based intervention would also be appro-
priate and effective for these patient groups. Therefore,
a web-based intervention with intensive therapeutic
support was developed for Dutch patients with all types
of eating disorders, including AN, BN, EDNOS and
BED [38]. The design and content of the intervention were
based on a comparable, successful web-based intervention
for problem drinkers [20,39].
In 2010, a pilot study tested the web-based intervention
with 165 patients with eating disorders to determine its ef-
fectiveness and feasibility [40]. A clinically relevant im-
provement between baseline and post treatment was found
for eating disorder psychopathology (measured with EDE-
Q, d = 1.17, p < .001) and body dissatisfaction (measured
with BAT; d = 0.86, p <0.001). Also quality of life (mea-
sured with the EuroQol-5D [EQ-5D], d = 0.32, p < .001),
mental health (measured with the Depression Anxiety
Stress Scale [DASS], d = 0.56, p < .001), and physical health
(measured with the Maudsley Addiction Profile Health
Symptom Scale [MAP-HSS] and 15 additional eating
disorder-specific complaints, d = 0.39, p < .001) clearly im-
proved. All of the effects, with the exception of
improvement in quality of life, were sustained at six-weeks
and six-months follow-up, and participants’ satisfaction
with the treatment program was high. However, the pilot
study had a nonrandomized design, so the observed
improvements could not be attributed exclusively to the
web-based treatment program. Furthermore, 46% of the
participants ended the web-based treatment program pre-
maturely and no post treatment and follow-up data were
available from these participants. Therefore, it was un-
known whether they benefited from participating in the
intervention. Accordingly, further research into the efficacy
of the web-based treatment program and into the group of
those who do not complete the program is needed.
Study aims
The primary aim of this study is to evaluate whether a
Dutch web-based treatment program with intensive
therapeutic support can improve eating disorder psycho-
pathology among female patients with BN, BED and
EDNOS. The secondary aim is to explore whether the
treatment program can also improve body image, physical
health, body weight, mental health, self-esteem, quality
of life, and social contacts. Additional aims include
examining participants’ acceptability of the web-based
treatment program, adherence to the program, reasons for
non-completion, the long-term treatment effects 3, 6 and
12 months after completing treatment, the influence of
motivation on treatment adherence and treatment ef-
fectiveness, the therapeutic alliance between the partic-
ipants (completers as well as non-completers) and their
therapists, the predictors of treatment effectiveness and
treatment adherence, and the additional value of partici-
pating in the online forum on the effect of treatment and
adherence to it. In line with the conclusions of the re-
view by Aardoom and colleagues [31], the involvement of
other interventions during treatment and follow-up, as
well as changes in medication use during treatment,
will also be monitored and reported.
Methods/design
Study design
The present study is a parallel-arm randomized controlled
trial that will compare the outcomes of participants
assigned to the experimental treatment group (web-
based treatment program) with those assigned to the
waiting list control group. Figure 1 presents a flow diagram
of the study.
Baseline data for both groups will be obtained from
the baseline questionnaire (Q0). After randomization, the
participants in the experimental treatment group will
immediately start with the web-based treatment program
while the participants assigned to the control group will
receive informational and supportive no-reply email
messages once every two weeks until they can start
with the web-based treatment program 15 weeks later.
A waiting period of 15 weeks was chosen, as this was
the average period of treatment in our pilot study and
we assume this will also be the case in the present
study. Before the participants in the control group can
begin the web-based treatment program, they will be
asked to complete the pre-intervention questionnaire
(QP) to determine whether there are any differences
between the baseline situation and the situation after
the 15-week waiting period.
Each participant in the experimental treatment group
will receive the post-test questionnaire (Q1) after com-
pleting the web-based treatment program. The post-test
questionnaire will measure primary and secondary out-
comes and the participant’s acceptability of the web-based
treatment program. In cases where participants in the
experimental treatment group do not fully complete
the web-based treatment program within 18 weeks, they
will receive the additional questionnaire (QA) 18 weeks
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after the start of the intervention. This questionnaire will
replace the post-test questionnaire (Q1) as the second
assessment, to set the period between the first and second
assessments as close as possible in both groups. Assess-
ment QA is identical to the post-test questionnaire
(Q1), with the exception of the questions to evaluate
the web-based treatment program.
The participants in both groups will receive a follow-up
questionnaire three, six, and 12 months after completing
the treatment program (assessments Q2, Q3 and Q4,
respectively).
Each participant who ends the web-based treatment
program prematurely will receive the evaluation ques-
tionnaire (QE) instead of the post-test questionnaire (Q1).
The evaluation questionnaire measures the participant’s
reasons for non-completing and the acceptability of the
web-based treatment program. In addition, the primary and
secondary outcomes will be measured. Each participant will
also receive the follow-up questionnaires (Q2, Q3 and Q4).
As a reward for completing the extensive questionnaires,
each participant will receive a €10.00 digital coupon to an
online store (www.bol.com) for each completed research
questionnaire. The baseline questionnaire (Q0) is an
exception, as this questionnaire is primarily relevant for
the therapist, whereas the other questionnaires are
primarily relevant for research purposes. Consequently,
each participant can receive a maximum of €50.00 for
completing all of the research questionnaires.
Setting
The participants’ personal setting can be any environment
of their choice that has internet access. In 2011, 94% of
the Dutch population had internet access in their homes,
and approximately 87% used the internet (almost) every
day [41]. In this way, patients throughout the country
can participate in the study. The therapists’ setting will
be the department ‘Web-based interventions’ of Tactus
Addiction Treatment, which is located in Enschede, the
Netherlands.
Participants
The study population will consist of female patients with
BN, BED and EDNOS. Based on the results of our pilot
study, we will exclude males and patients with AN, as
these patient groups were a minority in our pilot study.
Male patients and patients with AN will be offered
the possibility of participating in the regular web-based
treatment program without participating in the RCT.
Inclusion criteria
The inclusion criteria for the present study are: 1) female;
2) aged 18 years or older; 3) a diagnosis of BN, BED or
± 15 weeks  3 months    3 months           6 months
15 weeks   ± 15 weeks  3 months   3 months             6 months
Intervention
Email messages
Q0 =  Baseline questionnaire
Q1 =  Post-test questionnaire
Q2 =  Follow-up questionnaire 3 months 
Q3 =  Follow-up questionnaire 6 months 
Q4 =  Follow-up questionnaire 12 months 
QA =  Additional questionnaire for experimental treatment group in case the intervention is not finished 18 weeks after the start
QP =  Pre-intervention questionnaire for waiting list control group before the start of the intervention 
QE  =  Evaluation questionnaire after non-completion of the intervention
¹ Randomization will be stratified by type of eating disorder: BN, BED, EDNOS
Application 
for RCT
Experimental 
treatment 
group
Waiting list 
control group
Q1 Q2 Q3
Q0¹
Q4
Q1 Q2 Q4Q3
QE
QE
QA
QP
Figure 1 Flow diagram of the study.
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EDNOS; 4) access to and ability to use the internet; 5)
the ability to read and write Dutch; and 6) have given
informed consent.
Exclusion criteria
The exclusion criteria for the study are: 1) body weight
less than 85% of ideal body weight; 2) other psychological
and/or pharmaceutical treatment for eating disorders
in the past six months; 3) critical suicidal ideation
(suicidal plans or attempted suicide in the past month,
or attempted suicide once and suicidal thoughts in the past
month); 4) being pregnant; and 5) planning to be absent
for at least four weeks during the intervention period.
Recruitment
For recruitment, self-selection through a placed advertise-
ment will be used. Information regarding the web-based
treatment program and the trial can be found on the
Dutch website www.etendebaas.nl and on other Dutch
eating disorder-related websites and forums. We will
also place targeted advertisements in Dutch newspapers
and attempt to obtain free publicity for the intervention
and the study in newspapers and magazines.
Procedure
Participants will receive an email with an attachment
containing a description (in Dutch) of the research project
and the web-based intervention. Written informed
consent must be provided by each participant prior to
randomization. The consent form will include information
regarding withdrawal of consent, providing personal
information, and GP data.
Each participant will also complete the baseline ques-
tionnaire (Q0), which is an extensive online questionnaire
consisting of questions regarding eating attitudes and
behaviors, body dissatisfaction, physical and mental
health, and the personal situation of the participant.
Based on the replies given in the baseline questionnaire,
the investigator will evaluate whether the participant
meets the inclusion or exclusion criteria of the study.
An eating disorder diagnosis will be determined using an
online self-report questionnaire based on the DSM-IV
criteria for BN and the criteria described in Appendix
B of the DSM-IV-TR for BED. The Dutch version of
the Mini-International Neuropsychiatric Interview–Plus
(MINI-Plus) [42,43] will be used as a guideline. The
MINI-Plus is an appropriate measurement for daily
psychiatric practice and research purposes to determine
DSM-IV diagnoses in a standardized way [44]. Participants
with one or more eating disorder characteristics who do
not meet the criteria of BN or BED will be diagnosed with
EDNOS. An exception will be made for those participants
who meet the exclusion criterion “body weight less than
85% of ideal weight” which will be measured using the
weight table in the MINI-Plus part N (Anorexia Nervosa)
[43,44]. To assess this exclusion criterion, the participants
will be asked for their height and lowest body weight
in the three months prior to the study.
Participants who do not meet the inclusion criteria
and are therefore not eligible to participate in this study
will be informed of the possibility of participating in
the standard web-based treatment program without
having to participate in this study. Participants who
cannot participate in the web-based treatment program
(for example, because they already receive treatment
for their eating disorder at another institution or due to
urgent medical reasons) will be referred to their GP or
to a mental health institution.
Study intervention
Experimental treatment group
The web-based treatment program is part of an online
application for patients with eating disorders. The ap-
plication also includes an informational website (www.
etendebaas.nl) and a forum for peer support [38,40].
The contents and elements of the treatment program
are based on two evidence-based techniques: Cognitive
Behavioral Therapy [45-47] and Motivational Inter-
viewing [48,49].
During the web-based treatment program, all partici-
pants will have their own therapist with whom they
will communicate personally and asynchronously twice
a week, solely through the internet. There will be no
face-to-face or telephone contact during the treatment
period, unless participants specifically request this. The
asynchronous communication resembles email contact,
but will take place within a secure web-based application.
Participants will receive a response from their therapist
within three working days. Asynchronous contact was
chosen because it will give participants more autonomy to
decide when to participate in the treatment program, and
it enables them to think carefully about the responses they
will give to the therapist. The intensive and personalized
interaction between participants and their therapists is
one of the most essential elements of the web-based
treatment program and makes this intervention stand
out from online self-help programs and minimal-contact
therapies. The aim of the intense interaction is to optimize
the relationship between the participants and their thera-
pists, as the therapeutic alliance is positively associated
with treatment outcome in face-to-face treatment [50,51]
as well as web-based treatment [52,53]. However, so far
the therapeutic relationship has not been studied exten-
sively for web-based treatments on eating disorders [31].
All of the therapists working on the web-based treat-
ment program will have a bachelor’s degree in nursing or
social work or a master’s degree in psychology. Further-
more, they will complete an intensive two-day training
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program that focuses on motivational writing skills,
treatment methods for patients with eating disorders,
implementation of the treatment protocol, and the
technical aspects of delivering this web-based intervention.
Subsequently, all therapists will complete a full treatment
program with a test patient, after which they can start
under supervision as online therapists. Intensive super-
vision by highly experienced coaches will continue for at
least three months, during which a coach will provide
feedback on all therapists’ messages before they are sent
to the participants. These participants may join the treat-
ment program within their own personal environment at
any time that suits them. Therefore, no pre-determined
appointments will be required. The average duration of
the web-based treatment program will be 15 weeks, with
two contacts a week. Part 1 of the program will consist of
four assignments and at least seven contacts between the
participant and the therapist, with a focus on analyzing
the eating attitudes and behaviors of the participant. At
the end of Part 1, the participant will receive personal
advice from the therapist. Part 2 involves six assignments
and at least 14 contacts. This part of the treatment
program will start with setting goals for eating behavior,
exercising, weighing, and compensatory behaviors (if
applicable). The participants will learn to reach these
goals in five steps. In addition to receiving assignments,
the participants will also receive psycho education and
exercises. After completing the program, participants
may take part in an aftercare program consisting of six
weekly sessions. The purpose of this program will be to
support participants in their efforts to maintain the
changes achieved through the treatment program. During
the sessions, the therapist will respond to participants’
messages and the information registered in the eating
diary. Besides the aftercare sessions, there will be three
follow-up contacts, 3, 6 and 12 months after completion
of the treatment, in which the therapist will ask the
participant to complete the follow-up questionnaire. The
treatment sessions are presented in Figure 2.
All Dutch citizens have mandatory health care cover-
age. Dutch health insurance companies will reimburse
costs participants incur by taking part in this web-based
treatment program, with the possible exemption of a
participant contribution up to 350 euro.
Waiting list control group (no-reply e-mail messages)
The participants in the waiting list control group will
have to wait for 15 weeks after the randomization before
they can start taking part in the web-based intervention.
During this period, the participants will receive a no-reply
email from the researcher every two weeks to keep them
involved in the study. To avoid therapeutic support, the
participants in the waiting list control group cannot
reply to these messages. The email messages will include
information about eating behaviors and body image,
psycho education, motivational messages, and references
to the informational website and online forum.
Primary outcome measure
Primary outcome measure for this study will be an im-
provement in the eating disorder psychopathology. This
will be measured with the Eating Disorder Examination
Questionnaire (EDE-Q) [54,55]. The EDE-Q is a 36-item
self-report questionnaire, derived from the Eating Disorder
Examination Interview (EDE) [56]. The EDE-Q is widely
Treatment sessions
Application (baseline questionnaire)
Part 1
1 Welcome 
2 Register daily eating behavior (assignment 1)
3 Description of eating moments (assignment 2)
4 Analyzing eating situations (assignment 3)
5 Advantages and disadvantages (assignment 4)
6 Top three 
7 Personal advice 
Part 2
1 Setting goals (assignment 5)
2 To part 2 
3 Breaking habits
4 Changing thoughts (assignment 6)
5 Psycho-education or exercise
6 Changing behavior (assignment 7)
7 Psycho-education or exercise
8 Who am I (assignment 8)
9 Psycho-education or exercise
10 Decisions (assignment 9)
11 Psycho-education or exercise
12 Writing an action plan (assignment 10)
13 Psycho-education or exercise
14 Completion of treatment (post-test questionnaire)
Aftercare (optional)
1-6 Response to the participants’ messages and the 
information registered in the eating diary
Figure 2 Treatment sessions of the web-based
treatment program.
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used to assess the key behavioral features of eating
disorders and the severity of the psychopathology of
eating disorders. The EDE-Q consists of four subscales:
Restraint, Eating Concern, Shape Concern, and Weight
Concern. The items will be scored on a seven-point
Likert-type scale ranging from 0 to 6. The scores on
the four subscales account for the EDE-Q total score,
which will be the primary outcome measure in this
study. Validation studies of the EDE-Q have shown a
high level of agreement between the EDE-Q and EDE
in assessing the core attitudinal features of eating disorder
psychopathology in the general population [54,57], among
female substance abusers [58], and in clinical samples
of both BN and BED patients [59,60]. Luce & Crowther
[61] and Reas, Grilo & Masheb [62] also demonstrated
acceptable internal consistency and test-retest reliability.
Secondary outcome measures
Body dissatisfaction
The Body Attitude Test (BAT) developed by Probst and
colleagues [63-66] is a 20-item questionnaire measuring
the subjective perception and attitude of the participant
against her own body. The items will be scored on a
six-point Likert-type scale ranging from 0 to 5. A higher
score represents a more disordered body experience. The
cut-off score between patients with body dissatisfaction
and patients without body dissatisfaction is 36 [65].
Physical health
The physical complaints related to eating disorders will
be assessed using the Maudsley Addiction Profile-Health
Symptom Scale (MAP-HSS) [67]. This is a 10-item
structured interview, which was adapted from the
health scale of the Opiate Treatment Index [68]. Each
item will be scored on a five-point Likert-type scale
ranging from 0 (complaint never present in the previous
30 days) to 4 (complaint always present in the previous
30 days), resulting in a total scale-score ranging from 0
to 40. In previous research among opiate users, the
scores on the MAP-HSS were approximately evenly
distributed, the internal consistency of the scale was
satisfactory (α = 0.79), and the test-retest reliability of
the scale was high, with an intra-class correlation coef-
ficient amounting to 0.86 [67]. Because the MAP-HSS
only measures general physical complaints, 15 additional
items (dizziness/fainting; insomnia; hoarseness; sore
throat; palpitations; diarrhea; constipation; hair loss/
brittle hair; downy hair on face, arms, chest or back;
fluid accumulation in the legs; dry/scaly skin; rapidly
cold; dental problems; damaged back of the hand; swollen
glands) will be added to measure eating disorder-specific
physical complaints. The total score of physical complaints
will be determined by dividing the sum of the scores on
the MAP-HSS and the additional items by the total
number of items (n = 25).
Body weight
Body weight will be measured with one item: ‘What is
your current weight?’ Participants will be asked to fill in
their body weight in kilograms.
Mental health
The Depression Anxiety and Stress Scale-21 (DASS-21)
[69] is a 21-item self-report questionnaire assessing levels
of depression, anxiety and stress. Participants will be asked
to respond to each item to indicate the extent to which it
applies to them in the previous week. Each item will be
scored on a four-point scale ranging from 0 (did not apply
to me at all) to 3 (applied to me very much, or most of
the time). The DASS-21 has been shown to have high
concurrent validity (r = 0.84) and reliability (i.e. Cronbach’s
alpha of 0.94, 0.87 and 0.91 for the subscales depression,
anxiety and stress, respectively) [70].
Self-esteem
The Rosenberg Self-Esteem Scale (RSES) [71] is a widely
used self-report questionnaire consisting of 10-items to
measure an individual’s overall self-esteem. Higher numbers
represent higher levels of self-esteem. The RSES consists
of 10 statements, of which five are negative and five
positive. It has been demonstrated to be highly reliable
with Cronbach’s alphas in the range of 0.77 to 0.88 [72].
Quality of life
The EuroQol-5D (EQ-5D) [73] is a standardized measure
of health status, which can be used in the clinical and
economic evaluation of health care. The EQ-5D consists
of the ED-5D descriptive system and the EQ-5D visual
analogue scale (EQ VAS). The EQ-5D descriptive system
will measure quality of life on 5 dimensions: Mobility,
Self-care, Usual activities, Pain/discomfort, and Anxiety/
Depression. There are three levels of severity for each
item: (1) no problems, (2) some problems, (3) severe
problems. The scores on the 5 dimensions will be combined
in a 5-digit number describing the participant’s global
health state. A total of 243 possible health states are
described. The EQ VAS will record the participant’s
self-rated health on a visual analogue scale ranging
from 0 (‘Worst imaginable health state’) to 100 (‘Best
imaginable health state’).
Social contacts
Social contacts will be measured using three dimensions
of the MATE (Measurements in the Addictions for
Triage and Evaluation) part 7 ‘Activities & Participation,
Care & Support’: (1) interpersonal interactions and
relationships, (2) important areas of life, and (3) social
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life [74,75]. The MATE was constructed according to
the ICD and International Classification of Functioning
(ICF) in the World Health Organization (WHO) classi-
fication system. The dimension ‘interpersonal interac-
tions and relationships’ consists of 5 items, which will
be scored on a five-point Likert-type scale, ranging
from 1 (no / not applicable) to 5 (completely). The di-
mensions ‘important areas of life’ and ‘social life’ both
consist of 2 items, using the same five-point severity
scale.
Motivation for treatment
To measure motivation for treatment, the TCU Mo-
tivation for Treatment (MfT) [76] will be used. The
MfT questionnaire was originally developed to meas-
ure treatment motivation in people with alcohol de-
pendence, therefore, some textual adjustments will
be made to make it suitable for patients with eating
disorders.
Therapeutic alliance
The Helping Alliance Questionnaire (HAQ) is an 11-
item self-report questionnaire to give a quick and glo-
bal impression of the perception of the quality of the
working alliance between the participant and the ther-
apist [77,78]. The questionnaire contains two scales:
(1) ‘cooperation’, reflecting the participant’s perception
of the measure of help received from the care provider;
and (2) ‘helpfulness’, referring to the participant’s confi-
dence in his or her own capacity to improve the
situation.
Participants’ acceptability of the web-based treatment
program and satisfaction with their personal therapist
At post-treatment, the participants’ acceptability of the
program and satisfaction with their own personal ther-
apist will be measured. The participants will be asked
to identify those aspects of the treatment which they
consider to be most important, and to indicate how
pleasant, personal, and safe they found the treatment
program. The participants will also be asked to confirm
whether the web-based treatment program was effective
for them and whether they would recommend the
intervention to others. The participants will also have
to rate the treatment program and their own personal
therapist on a scale from 0 (very low) to 10 (very high).
Finally, they will have the opportunity to provide add-
itional comments.
Sample size and power calculation
The sample size is calculated with the statistical power
analyses program “G-power 3.1” by using a significance
level of 95% (p < .05), a power of 80%, the same number
of participants per condition (M 1:1), 2 groups, 2
measurements, a correlation among repeated measures
of 0.95, a mean difference (MD) score of 1.0, and a stand-
ard deviation (SD within group) of 1.2. The MD and SD
are based on the results of the EDE-Q total score dur-
ing our first study among 28 participants (results have
not been published). Based on this calculation 25 partici-
pants per condition (experimental treatment group, wait-
ing list control group) will be needed. However, some
participants will end the treatment program prematurely.
In the first study this amounted to 46% of the participants.
We expect this will be less during the RCT, given the
inclusion and exclusion criteria, the written informed
consent, and the completers rate within the RCT of
Ruwaard & Lange [37]. We expect that at least 60% of
the RCT participants will complete all treatment ses-
sions of the web-based treatment program. This means
that 42 participants per condition are needed. As we
want to measure the effectiveness of the web-based
treatment program for the specific eating disorder sub-
types BN, BED and EDNOS, we will need 42 partici-
pants per condition for all of the individual subtypes.
This brings the total number to 252 participants.
Randomization
The participants will be randomized to either the experi-
mental treatment group or the waiting list control group
via computer-generated randomly varying block sizes
(2, 4 or 8), stratified by type of eating disorder (BN,
BED, EDNOS). Block randomization will ensure that
equal numbers of participants will be recruited into
each subgroup (respectively, 42 participants in the BN
experimental group, BN control group, BED experimental
group, BED control group, EDNOS experimental group,
and EDNOS control group). The computer-generated
randomization will be prepared by a research assistant
who is not involved in either testing or implementing
the intervention. The lead investigator will be responsible
for the allocation of the participants to one of the two
groups. She will contact the research assistant every time a
new participant can be allocated to one of the two groups,
in order to ask the research assistant to which group the
next participant should be assigned. The lead investigator
will then assign the participant to that group via the
web-based application. The participant will receive an
automatic email which will indicate the group to which
she has been assigned.
Statistical analysis
All study data will be collected online on a secured
database server, which will be accessible only via firewall
and webserver through an SSL-secured (Secure Sockets
Layer) connection. All data will be stored daily as an
encrypted backup. Encryption keys for this backup will
be changed every six months. Frequency tables will be
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provided for all baseline, end of treatment, and follow-up
variables. Descriptive statistics will include mean, median,
and numbers of participants. If applicable, 95% confidence
intervals will be given. Chi-square and t-tests will be used
for demographic data and pre-treatment characteristics, to
assess whether randomization resulted in two comparable
groups at baseline and whether any differential loss to
follow-up has occurred. All participants of the study
will complete the intake questionnaire during the signing-
up stage. It is technically impossible to skip any of the
questions in the questionnaires. Therefore, pre-treatment
data will be available from all of these participants.
We will perform intention-to-treat analyses using
repeated measures analyses (Mixed Models) to measure
the effectiveness of the web-based treatment program
in terms of primary and secondary outcomes. Mixed
Model Repeated Measures will allow for the inclusion
of all the participants over time, regardless of missing
data. Between-group effect sizes will be calculated
based on the pooled standard deviation. Effect sizes of
d = .80 will be considered large [79]. Additionally,
post-hoc analyses will be used to compare the effects of
the web-based treatment program between the different
groups of participants (BN, BED and EDNOS).
Linear regression analyses will be used to determine
the predictors of improvement in eating disorder psycho-
pathology and logistic regression analyses will be used
to determine the predictors of premature termination
of the web-based treatment program.
Ethical approval
The study protocol was approved by the Ethics Committee
of Medical Spectrum Twente in March 2011 (reference
number NL31717.044.010, P10-31).
Discussion
The present study protocol presents the design of a
randomized controlled trial (RCT) to evaluate the effect-
iveness of a web-based treatment program for female
patients with BN, BED and EDNOS. The main purpose
of the treatment program will be to improve eating
disorder psychopathology. The treatment will also aim
to improve body image, physical health, body weight,
mental health, self-esteem, quality of life, and social
contacts. The participants will be followed for up to
12 months after completing the web-based treatment
program in order to assess the short and long-term
effectiveness of the program. Evaluation results will
provide the support necessary to design treatments that
are accessible, low-threshold and effective for female
patients with BN, BED and EDNOS. The results of the
trial will be published according to the CONSORT
statement [80].
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